These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1682457)

  • 1. Development and testing of bioadhesive, fluoride-containing slow-release tablets for oral use.
    Bottenberg P; Cleymaet R; de Muynck C; Remon JP; Coomans D; Michotte Y; Slop D
    J Pharm Pharmacol; 1991 Jul; 43(7):457-64. PubMed ID: 1682457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of salivary fluoride concentrations after administration of a bioadhesive slow-release tablet and a conventional fluoride tablet.
    Bottenberg P; Cleymaet R; de Muynck C; Remon JP; Coomans D; Slop D
    J Pharm Pharmacol; 1992 Aug; 44(8):684-6. PubMed ID: 1359097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficient fluoride enrichment using mucous membrane adhesives with slow release tablets].
    Bottenberg P
    Oralprophylaxe; 1991 Dec; 13(4):148-52. PubMed ID: 1818605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro/in vivo correlation of the bioadhesive properties of a buccal bioadhesive miconazole slow-release tablet.
    Bouckaert S; Lefebvre RA; Remon JP
    Pharm Res; 1993 Jun; 10(6):853-6. PubMed ID: 8321853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro bioadhesion of a buccal, miconazole slow-release tablet.
    Bouckaert S; Remon JP
    J Pharm Pharmacol; 1993 Jun; 45(6):504-7. PubMed ID: 8103096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of fluoride in the oral cavity after application of a bioadhesive fluoride-releasing tablet.
    Bottenberg P; Bultmann C; Gräber HG
    J Dent Res; 1998 Jan; 77(1):68-72. PubMed ID: 9437401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of extended release bioadhesive sodium fluoride tablets.
    Owens TS; Dansereau RJ; Sakr A
    Int J Pharm; 2005 Jan; 288(1):109-22. PubMed ID: 15607263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of multiple-unit floating-bioadhesive cooperative minitablets for improving the oral bioavailability of famotidine in rats.
    Zhu X; Qi X; Wu Z; Zhang Z; Xing J; Li X
    Drug Deliv; 2014 Sep; 21(6):459-66. PubMed ID: 24456044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical characterization and evaluation of buccal adhesive tablets containing omeprazole.
    Yong CS; Jung JH; Rhee JD; Kim CK; Choi HG
    Drug Dev Ind Pharm; 2001 May; 27(5):447-55. PubMed ID: 11448052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and in vivo evaluation of ocular minitablets prepared with different bioadhesive Carbopol-starch components.
    Weyenberg W; Bozdag S; Foreman P; Remon JP; Ludwig A
    Eur J Pharm Biopharm; 2006 Feb; 62(2):202-9. PubMed ID: 16209917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of bioadhesive polymers on the protective effect of fluoride against erosion.
    Ávila DM; Zanatta RF; Scaramucci T; Aoki IV; Torres CR; Borges AB
    J Dent; 2017 Jan; 56():45-52. PubMed ID: 27793704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucoadhesion, hydration and rheological properties of non-aqueous delivery systems (NADS) for the oral cavity.
    Zaman MA; Martin GP; Rees GD
    J Dent; 2008 May; 36(5):351-9. PubMed ID: 18343013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of salivary miconazole concentrations after administration of a bioadhesive slow-release buccal tablet and an oral gel.
    Bouckaert S; Schautteet H; Lefebvre RA; Remon JP; van Clooster R
    Eur J Clin Pharmacol; 1992; 43(2):137-40. PubMed ID: 1425869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary fluoride concentrations following applications of bioadhesive tablets and mouthrinses.
    Vivien-Castioni N; Gurny R; Baehni P; Kaltsatos V
    Eur J Pharm Biopharm; 2000 Jan; 49(1):27-33. PubMed ID: 10613924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a buccal bioadhesive nicotine tablet formulation for smoking cessation.
    Ikinci G; Senel S; Wilson CG; Sumnu M
    Int J Pharm; 2004 Jun; 277(1-2):173-8. PubMed ID: 15158980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral sustained-release bioadhesive tablet formulation of didanosine.
    Betageri GV; Deshmukh DV; Gupta RB
    Drug Dev Ind Pharm; 2001 Feb; 27(2):129-36. PubMed ID: 11266224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation development of oral controlled release tablets of hydralazine: optimization of drug release and bioadhesive characteristics.
    Singh B; Pahuja S; Kapil R; Ahuja N
    Acta Pharm; 2009 Mar; 59(1):1-13. PubMed ID: 19304554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QbD-Oriented Development and Characterization of Effervescent Floating-Bioadhesive Tablets of Cefuroxime Axetil.
    Bansal S; Beg S; Garg B; Asthana A; Asthana GS; Singh B
    AAPS PharmSciTech; 2016 Oct; 17(5):1086-99. PubMed ID: 26527606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and evaluation of bioadhesive buccal drug delivery of tizanidine hydrochloride tablets.
    Shanker G; Kumar CK; Gonugunta CS; Kumar BV; Veerareddy PR
    AAPS PharmSciTech; 2009; 10(2):530-9. PubMed ID: 19424804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and evaluation of lactoferrin bioadhesive tablets.
    Takahashi Y; Takeda C; Seto I; Kawano G; Machida Y
    Int J Pharm; 2007 Oct; 343(1-2):220-7. PubMed ID: 17600641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.